Pedarzani P, Mosbacher J, Rivard A, Cingolani L A, Oliver D, Stocker M, Adelman J P, Fakler B
Max-Planck Institut für Experimentelle Medizin, 37075 Göttingen, Germany.
J Biol Chem. 2001 Mar 30;276(13):9762-9. doi: 10.1074/jbc.M010001200. Epub 2000 Dec 27.
In most central neurons, action potentials are followed by an afterhyperpolarization (AHP) that controls firing pattern and excitability. The medium and slow components of the AHP have been ascribed to the activation of small conductance Ca(2+)-activated potassium (SK) channels. Cloned SK channels are heteromeric complexes of SK alpha-subunits and calmodulin. The channels are activated by Ca(2+) binding to calmodulin that induces conformational changes resulting in channel opening, and channel deactivation is the reverse process brought about by dissociation of Ca(2+) from calmodulin. Here we show that SK channel gating is effectively modulated by 1-ethyl-2-benzimidazolinone (EBIO). Application of EBIO to cloned SK channels shifts the Ca(2+) concentration-response relation into the lower nanomolar range and slows channel deactivation by almost 10-fold. In hippocampal CA1 neurons, EBIO increased both the medium and slow AHP, strongly reducing electrical activity. Moreover, EBIO suppressed the hyperexcitability induced by low Mg(2+) in cultured cortical neurons. These results underscore the importance of SK channels for shaping the electrical response patterns of central neurons and suggest that modulating SK channel gating is a potent mechanism for controlling excitability in the central nervous system.
在大多数中枢神经元中,动作电位之后会出现一个超极化后电位(AHP),它控制着放电模式和兴奋性。AHP的中慢成分被认为是由小电导钙激活钾(SK)通道的激活所致。克隆的SK通道是SKα亚基和钙调蛋白的异源复合物。这些通道通过钙与钙调蛋白结合而被激活,钙与钙调蛋白结合会诱导构象变化从而导致通道开放,而通道失活则是钙从钙调蛋白上解离所引发的相反过程。在此我们表明,SK通道门控受到1-乙基-2-苯并咪唑啉酮(EBIO)的有效调节。将EBIO应用于克隆的SK通道会使钙浓度-反应关系移至较低的纳摩尔范围,并使通道失活减慢近10倍。在海马CA1神经元中,EBIO增加了中慢AHP,强烈降低了电活动。此外,EBIO抑制了培养的皮层神经元中由低镁诱导的兴奋性过高。这些结果强调了SK通道在塑造中枢神经元电反应模式中的重要性,并表明调节SK通道门控是控制中枢神经系统兴奋性的一种有效机制。
Curr Drug Targets CNS Neurol Disord. 2004-6
Neuropharmacology. 2005-9
J Neurosci Res. 2023-11
Am J Physiol Cell Physiol. 2023-3-1
Pharmaceuticals (Basel). 2021-11-26
Cancers (Basel). 2021-12-17
Br J Pharmacol. 2022-2